The report covers the COPD Pipeline analysis at the global level along with all pipeline drugs approval timeline estimations. GervanoRA report’s aim at providing a better understanding of the pipeline competitive landscape with an expert analysis from experienced in-house professionals. The report provides the clear understanding of major unmet needs and opportunities, clear representation of driving forces and challenges along with a snapshot of the global therapeutic landscape of COPD. It facilitate in competitive counter planning and to build effective and success strategies to withstand day to day dynamics. The report also explains the improvement factors that influence the COPD research and development activities.